The inhibition of FOXO1 in CAR T cells, furthermore resulted in a more exhausted phenotype and weakened anti-tumor response, whereas overexpression of FOXO1 enhanced anti-tumor immunity, increased mitochondrial mass, and induced stemness (74, 75). The gene discussed is FOXO1; the disease is neoplasm.